Table 1.
All patients (n = 426) | Cervical cancer (n = 127) | Endometrial cancer (n = 203) | Ovarian cancer (n = 96) | ||
---|---|---|---|---|---|
n (%) | n (%) | n (%) | n (%) | ||
Age (years) | <50 | 145 (34.0) | 73 (57.4) | 39 (19.2) | 33 (34.3) |
≥51 | 281 (66.0) | 54 (42.5) | 164 (80.8) | 63 (65.6) | |
FIGO stage | I | 263 (61.7) | 95 (74.8) | 114 (56.2) | 54 (56.3) |
II | 58 (13.6) | 32 (25.2) | 19 (9.4) | 7 (7.3) | |
III | 97 (22.8) | 0 | 67 (33.0) | 30 (31.3) | |
IV | 8 (1.9) | 0 | 3 (1.5) | 5 (5.2) | |
Histology | SCC | – | 63 (49.6) | – | – |
EAC | – | – | 167 (82.3) | – | |
SAC | – | – | – | 24 (25.0) | |
Others | – | 64 (50.4) | 36 (17.7) | 72 (75.0) | |
Peritoneal cytologya | Negative | 330 (77.5) | 127 (100) | 155 (76.4) | 48 (50.0) |
Positive | 91 (21.4) | 0 (0) | 44 (21.7) | 47 (49.0) | |
WBC count (/μL) | ≥9000 | 46 (10.8) | 17 (13.4) | 17 (8.4) | 12 (12.5) |
<9000 | 380 (89.2) | 110 (86.6) | 186 (91.6) | 84 (87.5) |
FIGO International Federation of Gynecology and Obstetrics, SCC squamous cell carcinoma, EAC endometrioid adenocarcinoma, SAC serous adenocarcinoma, WBC white blood cell
aPeritoneal cytology was not indicated for 4 cases in endometrial cancer and 1 case in ovarian cancer.